Author: Piers Townley

A recent study highlights gaps in neuro-onoclogy services provided nationally

Recent research has shown that sex differences impact outcomes for people diagnosed with a glioblastoma. These differences go beyond hormone influences and were found to be intrinsic to tumour cells

We explore some of the barriers that will need to be overcome in order to implement the NHS Long Term Plan.

In this second part of our coverage we look at what’s missing form the NHS Long Term Plan

Today, the NHS Long Term Plan has been published setting out the future of NHS services. The plan has been eagerly awaited by healthcare professionals, charities and patients alike

Research, funded by us as part of the INSTINCT programme, has found differences between aggressive atypical teratoid rhabdoid tumours (ATRTs) and other brain tumours.

Our successful Ask the Researcher event will give you the chance to hear more about how we’re moving closer to a cure

The All Party Parliamentary Group on Children, Teenagers and Young Adults with Cancer (APPG CTYAC) is a cross-party group which is raising awareness and representing young people who have been personally affected by cancer

Our scientists in Heidelberg and London have discovered what drives the unpredictable growth of low grade brain tumours

On Wednesday we hosted a Parliamentary reception to celebrate the accomplishments and progress that has been made in this disease area since the launch of our strategy in 2015

Kelly Dawson’s appointment at Nottingham University Hospitals is part of our landmark strategy of improving the quality for all those diagnosed

Yesterday, we attended the Britain Against Cancer conference which celebrated 20 years of the All Party Parliamentary Group on Cancer (APPGC). Our Policy and Public Affairs Officer Helena Brown, reports.

SNO is an annual conference where those at the forefront of research to defeat brain tumours come together to share their work, discuss the progress that has been made and consider strategies for future development

We recently represented the charity at an international scientific conference called SNO in New Orleans

Hundreds more brain tumour patients are set to be offered access to experimental treatments over the next five years thanks to the Tessa Jowell BRAIN-MATRIX

Researchers have discovered a new drug could potentially halt the spread of glioblastoma cells

This month The Charity convened a series of meetings with a number of Assembly Members in Wales, lobbying them on some of the most important issues affecting brain tumour patients in Wales

Phil will join Rob Ritchie, whose ten year old son Toby, has a low grade brain tumour and others to scale the height of Everest on skis in just four days from 5 March 2019

Researchers have found a way to monitor diffuse midline gliomas (formerly known as DIPG) by measuring tumour biomarkers through a blood test

Today she told brain tumour experts and government ministers why she is determined to make the best cancer care accessible to millions, ‘not just to millionaires’, in honour of her mother’s legacy

Tyler praised for turning his challenges into a ‘force of good’

Scientists identify a subgroup of children diagnosed with medulloblastoma that could be given less aggressive treatments

Yesterday, new guidance has been provided to clinicians by NHS England for the prescription of medicinal cannabis but access to the drug remains highly restricted

The petition called for NHS England to commit to doubling survival rates for the less survivable cancers in the long term plan, due to be published next month